Gyre Therapeutics, Inc. GYRE Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Gyre Therapeutics, Inc. (GYRE) reported comprehensive income (loss), net of tax, attributable to parent of -$7.33M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Gyre Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 360.8% year-over-year, from $2.81M to -$7.33M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric captures all changes in equity during a period that are not derived from transactions with owners, including items like unrealized gains or losses on available-for-sale securities or foreign currency translation adjustments. It provides a more holistic view of the company's financial health beyond the standard net income figure. Investors use this to understand the total impact of market fluctuations and accounting adjustments on the company's net worth.